Literature DB >> 6780555

Isolation and structural characterization of human lymphocyte and neutrophil gangliosides.

B A Macher, J C Klock, M N Fukuda, M Fukuda.   

Abstract

Gangliosides were isolated from purified preparations of human peripheral blood lymphocytes and neutrophils. Structural analyses and comparisons were performed by direct probe mass spectrometry and by degradation studies with the following enzymes: Escherichia freundii endo-beta-galactosidase; Clostridium perfringens and Arthrobacter ureafaciens neuraminidase; and jack bean beta-N-acetylhexosaminidase and beta-galactosidase. This combination of techniques allowed us to obtain carbohydrate composition and sequence information without the aid of methylation or carbohydrate compositional analyses using only 1-2 mg of purified gangliosides. On the basis of these studies we propose that human lymphocytes and neutrophils have gangliosides with the following structures. NeuAc alpha 2 leads to 3Gal beta 1 leads to 4Glc beta 1 leads to 1Cer Structure A NeuAc alpha 2 leads to ? GlcNAc beta 1 leads to 3Gal beta 1 leads to 4Glc beta 1 leads to 1Cer Structure B NeuAc alpha 2 leads to ? Gal beta 1 leads to 3,4GlcNAc beta 1 leads to 3Gal beta 1 leads to 4Glc beta 1 leads to 1Cer Structure C All three compounds were isolated from both cell types with structure A being the major lymphocyte ganglioside and structure C the major neutrophil ganglioside. Structure B is a novel ganglioside and may represent a leukocyte-specific glycosphingolipid. Neuraminidase degradation studies demonstrated that only one ganglioside species of each cell type contains an internally linked sialic acid residue, and on the basis of thin layer chromatographic analysis this component is the same as the major brain ganglioside, GM1 (II3-N-acetylneuraminosyl-gangliotetraosylceramide). In addition, large gangliosides with the general structure NeuAc alpha 2 leads to ?(Gal beta 1 leads to 3,4GlcNAc beta 1 leads to 3)n Gal beta 1 leads to 4Glc beta 1 leads to 1Cer were isolated. These results are discussed as they relate to blood group antigens and specific cell surface markers in human leukocytes.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6780555

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

1.  Isolation of ergosterol peroxide and its reversion to ergosterol in the pathogenic fungus Sporothrix schenckii.

Authors:  D B Sgarbi; A J da Silva; I Z Carlos; C L Silva; J Angluster; C S Alviano
Journal:  Mycopathologia       Date:  1997       Impact factor: 2.574

2.  Endogenous sialylation of the lipooligosaccharides of Neisseria meningitidis.

Authors:  R E Mandrell; J J Kim; C M John; B W Gibson; J V Sugai; M A Apicella; J M Griffiss; R Yamasaki
Journal:  J Bacteriol       Date:  1991-05       Impact factor: 3.490

3.  Characterization of the ganglioside recognition profile of Escherichia coli heat-labile enterotoxin LT-IIc.

Authors:  Dani Zalem; Martin Juhás; Manuela Terrinoni; Natalie King-Lyons; Michael Lebens; Annabelle Varrot; Terry D Connell; Susann Teneberg
Journal:  Glycobiology       Date:  2022-04-21       Impact factor: 5.954

4.  Membrane differentiation in human myeloid cells: expression of unique profiles of cell surface glycoproteins in myeloid leukemic cell lines blocked at different stages of differentiation and maturation.

Authors:  M Fukuda; H P Koeffler; J Minowada
Journal:  Proc Natl Acad Sci U S A       Date:  1981-10       Impact factor: 11.205

5.  Characterization of cellular lipids in doxorubicin-sensitive and -resistant P388 mouse leukemia cells.

Authors:  W M Holleran; M W DeGregorio; R Ganapathi; J R Wilbur; B A Macher
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

Review 6.  Glycosphingolipids of normal and leukemic human leukocytes.

Authors:  B A Macher; W M Lee; M A Westrick
Journal:  Mol Cell Biochem       Date:  1982-09-03       Impact factor: 3.396

Review 7.  The Role of Glycosphingolipids in Immune Cell Functions.

Authors:  Tao Zhang; Antonius A de Waard; Manfred Wuhrer; Robbert M Spaapen
Journal:  Front Immunol       Date:  2019-01-29       Impact factor: 7.561

8.  The human natural anti-Gal IgG. III. The subtlety of immune tolerance in man as demonstrated by crossreactivity between natural anti-Gal and anti-B antibodies.

Authors:  U Galili; J Buehler; S B Shohet; B A Macher
Journal:  J Exp Med       Date:  1987-03-01       Impact factor: 14.307

9.  Lack of specificity of brain gangliosides in the modulation of lymphocyte activation.

Authors:  J L Ryan; L N Inouye; L Gobran; W B Yohe; H C Yohe
Journal:  Yale J Biol Med       Date:  1985 Sep-Oct

Review 10.  Vascular Diseases and Gangliosides.

Authors:  Norihiko Sasaki; Masashi Toyoda
Journal:  Int J Mol Sci       Date:  2019-12-17       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.